Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Yu

Showing results (81-90 of 360) with videos related to

Pageof 36
Sort By:
Journal of Geriatric Oncology|March 14, 2013
The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancerJennifer L Quon, James B Yu, Pamela R Soulos, et al.
Cancer|January 4, 2012
Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysisDaniela L Buscariollo, Henry S Park, Kenneth B Roberts, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|March 6, 2019
The case for radiotherapy in a Value based environmentPeter A S Johnstone, Susan Peneguy, Timothy N Showalter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2010
Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancerJames B Yu, Roy H Decker, Frank C Detterbeck, et al.
International Journal of Radiation Oncology, Biology, Physics|February 21, 2012
Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapyHenry S Park, Cary P Gross, Danil V Makarov, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 1, 2020
Geographic-Level Association of Contemporary Changes in Localized and Metastatic Prostate Cancer Incidence in the Era of Decreasing PSA ScreeningDaniel X Yang, Danil V Makarov, Cary P Gross, et al.
International Journal of Radiation Oncology, Biology, Physics|November 27, 2007
Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapyJames B Yu, Jennifer M McNiff, Molly W Lund, et al.
Clinical Lung Cancer|December 16, 2014
Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain MetastasesHenry S Park, Roy H Decker, Lynn D Wilson, et al.
Cancer|October 31, 2017
Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insuranceAmandeep R Mahal, Brandon A Mahal, Paul L Nguyen, et al.
American Journal of Clinical Oncology|November 7, 2014
Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer TypeVikram Jairam, James B Yu, Sanjay Aneja, et al.
Pageof 36

Showing results (81-90 of 360) with videos related to

Sort By:
Pageof 36
Journal of Geriatric Oncology|March 14, 2013
The relation between age and androgen deprivation therapy use among men in the Medicare population receiving radiation therapy for prostate cancerJennifer L Quon, James B Yu, Pamela R Soulos, et al.
Cancer|January 4, 2012
Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysisDaniela L Buscariollo, Henry S Park, Kenneth B Roberts, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|March 6, 2019
The case for radiotherapy in a Value based environmentPeter A S Johnstone, Susan Peneguy, Timothy N Showalter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2010
Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancerJames B Yu, Roy H Decker, Frank C Detterbeck, et al.
International Journal of Radiation Oncology, Biology, Physics|February 21, 2012
Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapyHenry S Park, Cary P Gross, Danil V Makarov, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 1, 2020
Geographic-Level Association of Contemporary Changes in Localized and Metastatic Prostate Cancer Incidence in the Era of Decreasing PSA ScreeningDaniel X Yang, Danil V Makarov, Cary P Gross, et al.
International Journal of Radiation Oncology, Biology, Physics|November 27, 2007
Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapyJames B Yu, Jennifer M McNiff, Molly W Lund, et al.
Clinical Lung Cancer|December 16, 2014
Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain MetastasesHenry S Park, Roy H Decker, Lynn D Wilson, et al.
Cancer|October 31, 2017
Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insuranceAmandeep R Mahal, Brandon A Mahal, Paul L Nguyen, et al.
American Journal of Clinical Oncology|November 7, 2014
Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer TypeVikram Jairam, James B Yu, Sanjay Aneja, et al.
Pageof 36